Byrne Asset Management LLC Sarepta Therapeutics, Inc. Transaction History
Byrne Asset Management LLC
- $112 Million
- Q1 2025
A detailed history of Byrne Asset Management LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Byrne Asset Management LLC holds 469 shares of SRPT stock, worth $25,621. This represents 0.03% of its overall portfolio holdings.
Number of Shares
469Holding current value
$25,621% of portfolio
0.03%Shares
2 transactions
Others Institutions Holding SRPT
# of Institutions
530Shares Held
85.9MCall Options Held
1.55MPut Options Held
1.35M-
Black Rock Inc. New York, NY10.3MShares$564 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$496 Million0.02% of portfolio
-
Capital International Investors Los Angeles, CA8.7MShares$475 Million0.21% of portfolio
-
Janus Henderson Group PLC London, X04.33MShares$236 Million0.28% of portfolio
-
State Street Corp Boston, MA4.07MShares$222 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $4.78B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...